Connection
Kelly Doran to Serotyping
This is a "connection" page, showing publications Kelly Doran has written about Serotyping.
|
|
Connection Strength |
|
 |
|
 |
|
0.256 |
|
|
|
-
Burcham LR, Spencer BL, Keeler LR, Runft DL, Patras KA, Neely MN, Doran KS. Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women. PLoS One. 2019; 14(12):e0226699.
Score: 0.173
-
van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, Doran KS. The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis. 2009 May 15; 199(10):1479-87.
Score: 0.083